<DOC>
	<DOCNO>NCT02612298</DOCNO>
	<brief_summary>The purpose study compare efficacy safety Arotinolol Hydrochloride Metoprolol succinate morning blood pressure , heart rate target organ damage patient essential hypertension . To provide evidence hypertension treatment . A group : Arotinolol Hydrochloride , oral , 5-15mg , bid 12 week . B group : Metoprolol succinate sustained-release tablet , oral , 23.75-71.25mg , qd 12 week .</brief_summary>
	<brief_title>Efficacy Safety Arotinolol Hydrochloride Morning Blood Pressure Heart Rate</brief_title>
	<detailed_description>Compare efficacy safety Arotinolol Hydrochloride Metoprolol succinate morning blood pressure , heart rate target organ damage patient essential hypertension .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Arotinolol</mesh_term>
	<criteria>1 . Patients systolic blood pressure 140179mmHg and/or diastolic blood pressure 90109mmHg . 2 . Aged 1865 year old . 3 . Signed informed consent . 1 . Secondary hypertension 2 . Patients take amiodarone 200mg/day control arrhythmia 3 . Patients take class I antiarrhythmic drug 4 . Resting heart rate less 60bpm 5 . Serious liver kidney disease : aspartate aminotransferase ( AST ) alanine aminotransferase ) ( ALT ) ＞2.5 time upper limit normal ; serum creatinine＞3mg/dl ( 265umol/L ) 6 . Severe heart failure : New York Heart Association ( NYHA ) functional class 2 , 3 , 4 7 . Myocardial infarction stroke last three month . Unstable angina pectoris last month . 8 . Patients asthma chronic obstructive pulmonary disease . 9 . Pregnancy breastfeed 10 . Patients allergy investigational drug contraindication investigational drug . 11 . Others unsuitable participate study judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Essential Hypertension</keyword>
	<keyword>Arotinolol</keyword>
	<keyword>Morning Blood Pressure</keyword>
</DOC>